Find helpful resources about Boston Scientific’s Drug-Eluting Technologies.
Case Study Videos
Treatment of a 76-year-old male patient with right anterior tibial and tibio-peroneal trunk occlusions using the Ranger™ Drug-Coated Balloon.
Click here to get access to the full-length case study video now.
Watch the recordings
Product Videos and Animation
Favorable twelve-month data for RANGER
Data demonstrated that the drug-coated balloon (DCB) exhibited both a high rate of primary patency and freedom from target lesion revascularization (TLR) at 12 months, reducing the need for re-interventions to re-establish flow in previously blocked blood vessels.
May 24, 2017
Endovascular Today, 2017
Download the Endovascular Today supplement and find out more on Drug-Eluting Technologies - Choosing the best option through data-informed decission making.
Endovascular Today, 2016
Download the Endovascular Today supplement and find out in a series of 12 articles how drug-eluting therapies are shaping a new era of endovascular interventions.
WANT TO KNOW MORE?
Join our Drug-Eluting Technologies Community
Sign Up for Product Updates
Receive the latest news of Drug Eluting TechnologiesSIGN UP